[{"Assets_0_Q3_USD":2148900000.0,"CommonStockSharesOutstanding_0_Q3_shares":46835044.0,"EarningsPerShareBasic_1_Q3_USD":0.35,"EarningsPerShareBasic_3_Q3_USD":1.0,"EarningsPerShareDiluted_1_Q3_USD":0.35,"EarningsPerShareDiluted_3_Q3_USD":0.98,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":80100000.0,"NetIncomeLoss_1_Q3_USD":16600000.0,"NetIncomeLoss_3_Q3_USD":46500000.0,"StockholdersEquity_0_Q3_USD":1180700000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":47600000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":47400000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":46800000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":46700000.0,"Ticker":"AVNS","CIK":"1606498","name":"HALYARD HEALTH, INC.","OfficialName":"Avanos Medical Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1515595188.0","Country":"United States","Sector":"Health Care","Industry":"Industrial Specialties","Market":"NYSE","SP500":"nan","filed":"20171101"}]